Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

CompletedOBSERVATIONAL
Enrollment

4,968

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2007

Study Completion Date

October 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

DMARD

All subjects were required to initiate, add or change DMARD therapy at study entry.

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Amgen

INDUSTRY